𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levamisole as adjuvant immunotherapy in breast cancer

✍ Scribed by Annette D. Treurniet-Donker; Marlies L. Meischke-De Jongh; Wim L. J. Van Putten

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
350 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant radiotherapy and chemotherapy i
Adjuvant radiotherapy and chemotherapy in breast cancer
✍ Mr C. S. McArdle; D. Crawford; E. H. Dykes; K. C. Calman; D. Hole; A. R. Russell πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 1 views
Role of adjuvant chemotherapy in male br
Role of adjuvant chemotherapy in male breast cancer
✍ Helen Z. Patel II; Aman U. Buzdar; Gabriel N. Hortobagyi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 287 KB πŸ‘ 2 views
Use of cellular and cytokine adjuvants i
Use of cellular and cytokine adjuvants in the immunotherapy of cancer
✍ Salgaller, Michael L.; Lodge, Patricia A. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Cellular and cytokine adjuvants, often immune effector cells and soluble factors, respectively, are supplemental and/or follow-up treatments of human origin for cancer patients who have unsatisfactory clinical responses to conventional chemotherapy, radiotherapy, and surgery. Since many human studie